GlassScriptPhysician profile
Robert N Suares
NPI 1275733636
$1,501.44
in general payments reported to CMS, 2019-2025
20 companies · $79.00 in 2025
The $79.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $121 · 2021: $259 · 2022: $309 · 2023: $115 · 2024: $377 · 2025: $79.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $310.81 | 2019-2025 | Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $214.00 | 2019-2022 | |
| Pfizer INC. | $204.54 | 2019-2023 | |
| Abbvie INC. | $148.60 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.11 | 2019-2022 | |
| Lilly USA, LLC | $70.60 | 2022-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $66.27 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $55.91 | 2019-2021 | |
| Amgen INC. | $48.25 | 2020-2024 | Otezla, Repatha |
| Amarin Pharma, INC. | $41.53 | 2020-2021 | |
| Mylan Specialty L.P. | $38.39 | 2019-2022 | |
| Exact Sciences Corporation | $36.27 | 2024 | Cologuard Collection Kit |
| Hikma Pharmaceuticals USA | $32.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $29.71 | 2021 | |
| Sunovion Pharmaceuticals INC. | $23.34 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.38 | 2022 | |
| Phathom Pharmaceuticals, INC. | $16.34 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $16.08 | 2022 | |
| Glaxosmithkline, LLC. | $14.70 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Suares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.